Cytokinetics | CYTK - Equity Capital And Reserves

Stock Price
62.22
Daily Change
-0.67 -1.07%
Monthly
-2.80%
Yearly
31.13%
Q1 Forecast
65.83

Cytokinetics reported $-659.62M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 917.27M 94.89M Sep/2025
Amgen USD 8.66B 961M Dec/2025
Arca Biopharma USD 486.79M 143.15M Sep/2025
Bayer EUR 29.7B 799M Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
Brainstorm Cell Therapeutics USD -7.69M 1.64M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Capricor Therapeutics USD 83.87M 21.11M Sep/2025
Cytokinetics USD -659.62M 138.5M Dec/2025
Eisai JPY 889.64B 35.21B Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Exelixis USD 2.16B 619K Dec/2025
Geron USD 248.71M 10.82M Sep/2025
Halozyme Therapeutics USD 48.81M 455.1M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
Ligand Pharmaceuticals USD 950.17M 121.64M Sep/2025
Merck USD 51.85B 2.79B Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025